WuXi XDC Cayman Inc.

Public

—N/Ahttps://www.wuxixdc.com

Last Round

Follow-on Offering

Sep 3, 2025

Total Funding Raised

$1.02B

Company Overview

WuXi XDC Cayman Inc. is a publicly traded Contract Research, Development, and Manufacturing Organization (CRDMO) that specializes in bioconjugates, with a primary focus on Antibody-Drug Conjugates (ADCs). Spun off from WuXi Biologics, the company offers a comprehensive, single-source platform of services from discovery and process development to GMP manufacturing of bioconjugates, monoclonal antibody intermediates, and payload-linkers. The company operates globally with facilities in China (Wuxi, Shanghai, Changzhou) and is expanding with a new site in Singapore to implement a "global dual sourcing" strategy. WuXi XDC was established as a joint venture in 2021 and went public on the Hong Kong Stock Exchange (stock code: 2268.HK) in November 2023.

AI Layer

Non-AI

Keywords

antibody-drug conjugate (ADC) CRDMOend-to-end bioconjugate servicesbioconjugate contract manufacturingsingle-source ADC development platformGMP bioconjugate manufacturingpayload and linker development and manufacturingaseptic fill and finish servicesmonoclonal antibody intermediate manufacturingbioconjugation process developmentanalytical development for bioconjugatesglobal dual-sourcing for biopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WuXi XDC Cayman Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

WuXi XDC Cayman Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Follow-on Offering	Sep 3, 2025
IPO Announced	Nov 17, 2023
Corporate Funding	May 14, 2021

View all Funding Rounds

WuXi XDC Cayman Inc. Investors

Notable investors and investment history

Investor	Rounds
Credit Suisse Asset Management	IPO
WuXi STA	Corporate Funding
General Atlantic	IPO
Qatar Investment Authority	IPO

View all Investors

WuXi XDC Cayman Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

WuXi XDC Cayman Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range301

Year Founded2021

Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.